| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Medical Research Council Group in Molecular Endocrinology, Research Centre, Laval University Medical Centre Québec, G1V 4G2, Canada
Address requests for reprints to: Professor Fernand Labrie, MRC Group in Molecular Endocrinology, Research Centre, Laval University Medical Centre, 2705 Laurier Boulevard, Québec G1V4G2; Canada.
Abstract
Two human 17β-hydroxysteroid dehydrogenase (17β-HSD) genes (h17β-HSDI and h17β-HSDII) included in tandem within an approximately 13 kilobase pair fragment were isolated from a genomic
EMBL3 DNA library using cDNA encoding human 17β-HSD (hpE2DH216) as probe. We have determined the complete exon and intron sequences of the two genes as well as their 5' and 3'-flanking regions. Human 17β-HSDII contains six exons and five short introns for a total length of 3250 base pairs. The exon sequence of h17β-HSDII is identical to the previously reported hpE2DH216 cDNA while the overlapping nucleotide sequences of the corresponding exons and introns of h17β-HSDI and h170-HSDII show 89% homology. In addition, we have used the hpE2DH216 cDNA to demonstrate the widespread expression of 17β-HSD mRNAs in steroidogenic and peripheral target tissues. These new findings provide the basis for a better understanding of the molecular mechanisms involved in 17β-HSD deficiency and peripheral sex steroid metabolism.
Received for publication August 8, 1989. Revision received October 23, 1989. Accepted for publication October 30, 1989.
This article has been cited by other articles:
![]() |
R.-S. Wang, S. Yeh, C.-R. Tzeng, and C. Chang Androgen Receptor Roles in Spermatogenesis and Fertility: Lessons from Testicular Cell-Specific Androgen Receptor Knockout Mice Endocr. Rev., April 1, 2009; 30(2): 119 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, A. Belanger, V. Luu-The, C. Labrie, J. Simard, L. Cusan, J. Gomez, and B. Candas Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer Endocr. Rev., May 1, 2005; 26(3): 361 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Setiawan, S. E. Hankinson, G. A. Colditz, D. J. Hunter, and I. De Vivo HSD17B1 Gene Polymorphisms and Risk of Endometrial and Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 213 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Suzuki, H. Sasano, S. Andersson, and J. I. Mason 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5->4-Isomerase Activity Associated with the Human 17{beta}-Hydroxysteroid Dehydrogenase Type 2 Isoform J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3669 - 3672. [Abstract] [Full Text] |
||||
![]() |
Q. Han, R. L. Campbell, A. Gangloff, Y.-W. Huang, and S.-X. Lin Dehydroepiandrosterone and Dihydrotestosterone Recognition by Human Estrogenic 17beta -Hydroxysteroid Dehydrogenase. C-18/C-19 STEROID DISCRIMINATION AND ENZYME-INDUCED STRAIN J. Biol. Chem., January 14, 2000; 275(2): 1105 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Leivonen, Y.-s. Piao, H. Peltoketo, P. Numchaisrika, R. Vihko, and P. Vihko Identification of Essential Subelements in the hHSD17B1 Enhancer: Difference in Function of the Enhancer and That of the hHSD17BP1 Analog Is due to -480C and -486G Endocrinology, August 1, 1999; 140(8): 3478 - 3487. [Abstract] [Full Text] |
||||
![]() |
V. L. Green, V. Speirs, A. M. Landolt, P. M. Foy, and S. L. Atkin 17{beta}-Hydroxysteroid Dehydrogenase Type 1, 2, 3, and 4 Expression and Enzyme Activity in Human Anterior Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1340 - 1345. [Abstract] [Full Text] |
||||
![]() |
A. M. Corbould, S. J. Judd, and R. J. Rodgers Expression of Types 1, 2, and 3 17{beta}-Hydroxysteroid Dehydrogenase in Subcutaneous Abdominal and Intra-Abdominal Adipose Tissue of Women J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 187 - 194. [Abstract] [Full Text] |
||||
![]() |
C. M. HAQQ and P. K. DONAHOE Regulation of Sexual Dimorphism in Mammals Physiol Rev, January 1, 1998; 78(1): 1 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Moghrabi, J. R. Head, and S. Andersson Cell Type-Specific Expression of 17{beta}-Hydroxysteroid Dehydrogenase Type 2 in Human Placenta and Fetal Liver J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3872 - 3878. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. M. Castagnetta, G. Carruba, A. Traina, O. M. Granata, M. Markus, M. Pavone-Macaluso, C. H. Blomquist, and J. Adamski Expression of Different 17{beta}-Hydroxysteroid Dehydrogenase Types and Their Activities in Human Prostate Cancer Cells Endocrinology, November 1, 1997; 138(11): 4876 - 4882. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-s. Piao, H. Peltoketo, P. Vihko, and R. Vihko The Proximal Promoter Region of the Gene Encoding Human 17{beta}-Hydroxysteroid Dehydrogenase Type 1 Contains GATA, AP-2, and Sp1 Response Elements: Analysis of Promoter Function in Choriocarcinoma Cells Endocrinology, August 1, 1997; 138(8): 3417 - 3425. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Puranen, M. Poutanen, D. Ghosh, R. Vihko, and P. Vihko Origin of Substrate Specificity of Human and Rat 17{beta}-Hydroxysteroid Dehydrogenase Type 1, Using Chimeric Enzymes and Site-Directed Substitutions Endocrinology, August 1, 1997; 138(8): 3532 - 3539. [Abstract] [Full Text] |
||||
![]() |
T. M. Penning Molecular Endocrinology of Hydroxysteroid Dehydrogenases Endocr. Rev., June 1, 1997; 18(3): 281 - 305. [Abstract] [Full Text] |
||||
![]() |
Y.-s. Piao, H. Peltoketo, A. Jouppila, and R. Vihko Retinoic Acids Increase 17{beta}-Hydroxysteroid Dehydrogenase Type 1 Expression in JEG-3 and T47D Cells, but the Stimulation Is Potentiated by Epidermal Growth Factor, 12-O-Tetradecanoylphorbol-13-Acetate, and Cyclic Adenosine 3',5'-Monophosphate Only in JEG-3 Cells Endocrinology, March 1, 1997; 138(3): 898 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Maxwell, J. Nearing, and N. Aziz Ke 6 Gene J. Biol. Chem., October 20, 1995; 270(42): 25213 - 25219. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. O'Shea, M. J. Gast, G. L. Murdock, R. M. Payne, and A. W. Strauss Original ArticlesExpression of Engineered Human I7{beta}-Estradiol Dehydrogenase in a Prokaryotic System Reproductive Sciences, April 1, 1994; 1(2): 143 - 149. [Abstract] [PDF] |
||||
![]() |
J. Hall, M. Lee, B Newman, J. Morrow, L. Anderson, B Huey, and M. King Linkage of early-onset familial breast cancer to chromosome 17q21 Science, December 21, 1990; 250(4988): 1684 - 1689. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |